ICU mortality · adults requiring mechanical ventilation
Semi‐recumbent position (30º to 60º) showed no clear difference in ICU mortality compared with supine position (0° to 10°) (low certainty).
1 finding from 1 review
Hospital mortality · adults requiring mechanical ventilation
Semi‐recumbent position (30º to 60º) showed no clear difference in hospital mortality compared with supine position (0° to 10°) (low certainty).
1 finding from 1 review
Duration of ICU stay · adults requiring mechanical ventilation
Semi‐recumbent position (30º to 60º) showed no clear difference in length of ICU stay compared with supine position (0° to 10°) (moderate certainty).
1 finding from 1 review
Length of hospital stay · adults requiring mechanical ventilation
It is very uncertain whether semi‐recumbent position (30º to 60º) changes length of hospital stay compared with supine position (0° to 10°) (very low certainty).
1 finding from 1 review
Clinically suspected VAP · adults requiring mechanical ventilation
It is very uncertain whether semi‐recumbent positioning: 45° changes clinically suspected VAP compared with 25° to 30° (very low certainty).
1 finding from 1 review
Microbiologically confirmed VAP · adults requiring mechanical ventilation
It is very uncertain whether semi‐recumbent positioning: 45° changes microbiologically confirmed VAP compared with 25° to 30° (very low certainty).
1 finding from 1 review
Intervention not reported
Absence of symptoms at 48 hours ‐ patient assessment
The intervention may leads to higher absence of symptoms at 48 hours ‐ patient assessment (low certainty).
1 finding from 1 review
Rubella cases Initial meta‐analysis ‐ clinical diagnosis or serology +/‐ virus isolation +/‐ clinical signs · susceptible people exposed to rubella
Gamma‐globulin probably leads to lower rubella cases Initial meta‐analysis ‐ clinical diagnosis or serology… compared with control (saline or no treatment) (moderate certainty).
1 finding from 1 review
Subgroup: rubella cases Estimated dose 0.027 to 0.037 ml/lb11 Clinical diagnosis by 2 physicians · susceptible people exposed to rubella
Gamma‐globulin showed no clear difference in subgroup: rubella cases Estimated dose 0.027 to 0.037 ml/lb11… compared with control (saline or no treatment) (low certainty).
1 finding from 1 review
Subgroup: rubella cases Estimated dose 0.1 to 0.15 ml/lb11 Serology +/‐ virus isolation +/‐ clinical signs · susceptible people exposed to rubella
Gamma‐globulin leads to lower subgroup: rubella cases Estimated dose 0.1 to 0.15 ml/lb11 Serology… compared with control (saline or no treatment) (high certainty).
1 finding from 1 review
Subgroup: rubella cases Estimated dose 0.2 to 0.5 ml/lb11 Serology +/‐ virus isolation +/‐ clinical signs · susceptible people exposed to rubella
Gamma‐globulin showed no clear difference in subgroup: rubella cases Estimated dose 0.2 to 0.5 ml/lb11 Serology… compared with control (saline or no treatment) (moderate certainty).
1 finding from 1 review
Cases of congenital rubella infection ‐ not measured · susceptible people exposed to rubella
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cases of congenital rubella syndrome ‐ not measured · susceptible people exposed to rubella
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ not measured · susceptible people exposed to rubella
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Incidence of pulmonary tuberculosis in children with HIV infection ‐ isoniazid prophylaxis only · children with HIV infection aged 12 years and under
The intervention showed no clear difference in incidence of pulmonary tuberculosis in children with HIV infection ‐… (moderate certainty).
1 finding from 1 review
Intervention not reported
Episodes of pulmonary exacerbations ‐ azithromycin prophylaxis only · children with cystic fibrosis aged 12 years and under
The intervention leads to lower episodes of pulmonary exacerbations ‐ azithromycin prophylaxis only (high certainty).
1 finding from 1 review
Intervention not reported
Incidence of Pneumocystis carinii pneumonia infection in children with cancer ‐ trimethoprim‐sulfamethoxazole prophylaxis only · children with cancers aged 12 years and under
The intervention probably leads to lower incidence of Pneumocystis carinii pneumonia infection in children… (moderate certainty).
1 finding from 1 review
Intervention not reported
Mortality in children with HIV infection ‐ overall · children with HIV infection aged 12 years and under
The intervention showed no clear difference in mortality in children with HIV infection ‐ overall (moderate certainty).
1 finding from 1 review
Intervention not reported
Mortality in children with HIV infection ‐ co‐trimoxazole prophylaxis only · children with HIV infection aged 12 years and under
The intervention probably leads to lower mortality in children with HIV infection ‐ co‐trimoxazole… (moderate certainty).
1 finding from 1 review
Intervention not reported
Mortality in children with HIV infection ‐ isoniazid prophylaxis only · children with HIV infection aged 12 years and under
The intervention showed no clear difference in mortality in children with HIV infection ‐ isoniazid prophylaxis only (low certainty).
1 finding from 1 review